Saudi Arabia vs Singapore: Number of clinical trials
Saudi Arabia
58
in 2024
Singapore
57
in 2024
Saudi Arabia rank
33rd
Singapore rank
35th
Number of clinical trials over time
- Saudi Arabia
- Singapore
How they compare
Saudi Arabia currently reports 58 against 57 in Singapore, a difference of 1.
The two have swapped places 3 times across 19 shared years of data; in 2005 it was Singapore ahead.
Saudi Arabia ranks 33rd and Singapore ranks 35th of 153 countries.
Across the 3 decades both report, Saudi Arabia averaged higher in 1 and Singapore in 2.
Head to head by decade
| Decade | Saudi Arabia | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.25 | 18 | 14.75 | Singapore |
| 2010s | 22.5 | 53.2 | 30.7 | Singapore |
| 2020s | 79.6 | 72 | 7.6 | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of clinical trials, Saudi Arabia or Singapore?
- Saudi Arabia, at 58 against 57 in Singapore as of 2024.
- What is the difference in number of clinical trials between Saudi Arabia and Singapore?
- 1, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and Singapore?
- 19 years are reported by both, from 2005 to 2024.
- How do Saudi Arabia and Singapore rank globally for number of clinical trials?
- Saudi Arabia ranks 33rd and Singapore ranks 35th of 153 countries.
- Where does this data come from?
- Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.